[HTML] sciencedirect.com

[HTML][HTML] Continuing controversy regarding individualized surgical decision-making for patients with 1–4 cm low-risk differentiated thyroid carcinoma: a systematic …

W Liu, X Yan, R Cheng - European Journal of Surgical Oncology, 2020 - Elsevier
Implementing high-quality randomized controlled trials is difficult for patients with 1–4 cm
low-risk differentiated thyroid carcinoma (DTC). Controversy exists regarding whether …
被引用次数：19 相关文章

Continuing controversy regarding individualized surgical decision-making for patients with 1-4 cm low-risk differentiated thyroid carcinoma: A systematic review.

W Liu, X Yan, R Cheng - … Journal of Surgical Oncology: the Journal …, 2020 - europepmc.org
Implementing high-quality randomized controlled trials is difficult for patients with 1-4 cm low-
risk differentiated thyroid carcinoma (DTC). Controversy exists regarding whether lobectomy …

Continuing controversy regarding individualized surgical decision-making for patients with 1-4 cm low-risk differentiated thyroid carcinoma: A systematic review

W Liu, X Yan, R Cheng - European journal of surgical …, 2020 - pubmed.ncbi.nlm.nih.gov
Implementing high-quality randomized controlled trials is difficult for patients with 1-4 cm low-
risk differentiated thyroid carcinoma (DTC). Controversy exists regarding whether lobectomy …

Continuing controversy regarding individualized surgical decision-making for patients with 1–4 cm low-risk differentiated thyroid carcinoma: A systematic review

W Liu, X Yan, R Cheng - European Journal of Surgical Oncology, 2020 - ejso.com
Implementing high-quality randomized controlled trials is difficult for patients with 1–4 cm
low-risk differentiated thyroid carcinoma (DTC). Controversy exists regarding whether …